Correlation Engine 2.0
Clear Search sequence regions

filter terms:
  • glycol (1)
  • prodrugs (7)
  • proteases (1)
  • serum (4)
  • Sizes of these terms reflect their relevance to your search.

    Due to the increasing prominence of antibiotic resistance, novel drug discovery and delivery approaches targeting bacteria are essential. In this work we evaluate a prodrug design to improve the cytotoxic profile of polycationic oligothioetheramides (oligoTEAs), which are promising antimicrobials. Herein we chemically modify the oligoTEA, PDT-4G, with a polyethylene glycol (PEG) and show that 1, 2, and 5 kDa PEGs mitigate cytotoxicity. As PEGylation reduces antibacterial activity, we evaluate two peptide linkers which, unlike oligoTEAs, are susceptible to proteolytic cleavage in serum. To gain insight into the prodrug reactivation, two linkers were tested, the 5-residue peptide sequence LMPTG, and the dipeptide sequence VC-PABC. In the presence of 20 % serum, prodrugs made with the VC-PABC linker successfully inhibited bacterial growth. Overall, we observed reactivation of oligoTEAs facilitated by serum protease cleavage of the peptide linkers. This work opens the door to the future design of antimicrobial prodrugs with tunable release profiles. © 2021 Wiley-VCH GmbH.


    Christine M Artim, Manisha Kunala, Meghan K O'Leary, Christopher A Alabi. PEGylated Oligothioetheramide Prodrugs Activated by Host Serum Proteases. Chembiochem : a European journal of chemical biology. 2021 Sep 02;22(17):2697-2702

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 34227209

    View Full Text